Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms
The Trump administration has struck new drug pricing agreements with nine biotech and pharmaceutical companies including UCB SA, Bridgebio Pharma Inc. and Sun Pharmaceutical Industries Ltd. As part of the deal, the companies will provide discounts…
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Donald Trump announces pharma deal: List of drugs getting prices reduced
President Donald Trump on Monday announced agreements with nine additional drug manufacturers as part of his administration's effort to lower prescription drug costs. The agreements are part of the administration's 'Most Favored Nation' (MFN) drug…
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss…
PMV Pharma announces proposed public offering (PMVP:NASDAQ)
PMV Pharmaceuticals () said on Monday it launched an underwritten public offering of common stock and accompanying warrants. The company may also offer pre-funded warrants to certain investors in lieu of common stock, along with accompanying…
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs (NYSEARCA:XLV)
Nine of the 16 Big Pharma stocks covered in this article set new 52-week highs during August, reflecting strong momentum across the sector. Also, the rally has been driven by strong Q2 results, as well as Wall Street's growing shift toward…
Trump Secures Drug Pricing Deals With Nine Pharma Companies
President Donald Trump announced new drug pricing agreements with nine pharmaceutical companies on Monday, expanding his administration's campaign to lower prescription drug costs for Americans. The agreements involve Astellas, BeOne Medicines…
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ('Innocan' or the 'Company'), today reported today 2026…
Sun Pharma signs US MFN pricing agreement for Medicaid programmes
India's Sun Pharmaceutical Industries is among nine drugmakers that have signed an agreement with the United States government to extend “Most Favoured Nation” (MFN) pricing in America. The company said it would extend MFN pricing to…
Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of 'Buy' from Brokerages
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have earned a consensus recommendation of 'Buy' from the twenty ratings firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with…
Stock market today: Dow, S&P 500, Nasdaq futures fall as inflation, Fed rate-hike fears persist
US stock futures meandered on Tuesday morning as uncertainty around the war in Iran, the bond market, and the Fed's next interest rate move largely kept buyers on the sidelines. Futures on the Dow Jones Industrial Average (YM=F) and S&P 500 (ES=F)…
Ascendis Pharma A/S (NASDAQ:ASND) Trading Up 7.3% - Here's Why
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) rose 7.3% during trading on Monday. The company traded as high as $266.17 and last traded at $266.06. Approximately 172,528 shares changed hands during trading, a decline of 74% from the…
Two Sigma Securities LLC Takes $1.32 Million Position in BridgeBio Pharma, Inc. $BBIO
Two Sigma Securities LLC bought a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 17,689…
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 6% - Should You Sell?
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) fell 6% on Monday. The stock traded as low as $17.19 and last traded at $17.1850. 2,433 shares traded hands during mid-day trading, a decline of 64%…
The big losers in the markets today
Among the 30 Sensex firms, Adani Ports fell the most by 4.11 per cent. Index major HDFC Bank reversed early gains to close down by 1.53 per cent as its CEO and Managing Director Sashidhar Jagdishan announced that he will opt for reappointment after…
Receive a Daily briefing on Pharma Industry News
Get Started